Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q4 FY262026-06-30 | Q3 FY262026-03-31 | Q2 FY262025-12-31 | Q1 FY262025-09-30 | Q4 FY252025-06-30 | Q3 FY252025-03-31 | Q2 FY252024-12-31 | Q1 FY252024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B |
| Cost of revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B |
| Gross profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B |
| Gross margin | 4.0% | 4.1% | 3.7% | 3.6% | 3.7% | 3.9% | 3.5% | 3.6% |
| Selling, general and administrative | $1.63B | $1.54B | $1.50B | $1.46B | $1.48B | $1.32B | $1.31B | $1.28B |
| Operating expenses | $1.83B | $1.80B | $1.69B | $1.65B | $1.74B | $1.41B | $1.39B | $1.34B |
| Operating income | $733.00M | $694.00M | $707.00M | $670.00M | $461.00M | $713.00M | $549.00M | $567.00M |
| Operating margin | 1.2% | 1.1% | 1.1% | 1.0% | 0.8% | 1.3% | 1.0% | 1.1% |
| EBITDA | $1.01B | $978.00M | $930.00M | $923.00M | $688.00M | $843.00M | $722.00M | $733.00M |
| Interest expense | −$79.00M | −$101.00M | −$88.00M | −$80.00M | −$74.00M | −$74.00M | −$35.00M | −$32.00M |
| Income before taxes | $554.00M | $392.00M | $630.00M | $598.00M | $384.00M | $665.00M | $511.00M | $541.00M |
| Income taxes | $154.00M | $12.00M | $159.00M | $144.00M | $141.00M | $157.00M | $110.00M | $124.00M |
| Net income | $400.00M | $380.00M | $471.00M | $454.00M | $243.00M | $508.00M | $401.00M | $417.00M |
| Net margin | 0.6% | 0.6% | 0.7% | 0.7% | 0.4% | 0.9% | 0.7% | 0.8% |
| EPS, basic | $1.69 | $1.69 | $1.98 | $1.89 | $1.00 | $2.11 | $1.65 | $1.71 |
| EPS, diluted | $1.69 | $1.69 | $1.97 | $1.88 | $1.00 | $2.10 | $1.65 | $1.70 |
| Diluted shares | 236.00M | 236.00M | 237.00M | 239.00M | 239.00M | 241.00M | 243.00M | 245.00M |
Figures describe Cardinal Health shares, not any token. As of Aug 11, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.